Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Androgen deprivation therapy and cardiac function: effects of endurance training

Prostate Cancer and Prostatic Diseases volume 9, pages 392–398 (2006)Cite this article

Abstract

Purpose: This study examined the effects of an 8-week androgen deprivation therapy treatment using Zoladex and an endurance training regimen on cardiac function.

Methods: Male Sprague–Dawley rats received either Zoladex or placebo. Animals remained sedentary or endurance trained during the drug treatment period. On day 57, ex vivo cardiac function was analyzed.

Results: Hearts from sedentary animals receiving Zoladex possessed significant cardiac dysfunction. However, hearts from exercise trained rats receiving Zoladex possessed cardiac function values similar to those from hearts from placebo animals.

Conclusions: An 8-week treatment with Zoladex promoted cardiac dysfunction. Endurance training during Zoladex treatment protected against this cardiac dysfunction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Labrie F, Cusan L, Gomez JL, Diamond P, Candas B . Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality. J Clin Endocrinol Metab 1995; 80: 2002–2012.

    CAS  PubMed  Google Scholar 

  2. Härkönen P, Törn S, Kurkela R, Povari K, Pulkka A, Lindfors A et al. Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J Clin Endocrinol Metab 2003; 88: 705–712.

    Article  Google Scholar 

  3. Rashid MH, Chaudary UB . Intermittent androgen deprivation therapy for prostate cancer. Oncologist 2004; 9: 295–301.

    Article  CAS  Google Scholar 

  4. Furr BJ . Pharmacology of the leuteinizing-releasing hormone (LHRH) analogue, Zoladex. Horm Res 1989; 32: S86–S92.

    Article  Google Scholar 

  5. Higano CS . Side effects of androgen deprivation therapy: monitoring and minimizing toxicities. Urology 2003; 61: S32–S38.

    Article  Google Scholar 

  6. Chen AC, Petrylak DP . Complications of androgen-deprivation therapy in men with prostate cancer. Current Urol Rep 2005; 6: 210–216.

    Article  Google Scholar 

  7. Saad F, Olsson C, Schulman CC . Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care. Eur Urol 2004; 46: 731–739.

    Article  Google Scholar 

  8. Scheuer J, Malhotra A, Capasso J . Effetcs of gonadectomy and hormonal replacement on rat hearts. Circ Res 1987; 61: 12–19.

    Article  CAS  Google Scholar 

  9. Jin H et al. Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am J Physiol 2002; 279: H2994–H3002.

    Google Scholar 

  10. Stolen KQ, Kemppainen J, Ukkonen H, Kalliokosi KK, Luotolahti M, Hämäläinen H et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency inpatients with dilated cardiomyopathy. J Am Coll Cardiol 2003; 41: 460–467.

    Article  CAS  Google Scholar 

  11. Chicco AJ, Hydock DS, Schneider CM, Hayward R . Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity. J Appl Physiol 2006; 100: 519–527.

    Article  CAS  Google Scholar 

  12. Chicco AJ, Schneider CM, Hayward R . Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol 2005; 289: R424–R431.

    CAS  Google Scholar 

  13. Talmadge RJ, Roy RR . Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 1993; 75: 2337–2340.

    Article  CAS  Google Scholar 

  14. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ . Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998; 98: 256–261.

    Article  CAS  Google Scholar 

  15. Golden KL, Marsh JD, Jiang Y, Brown T, Moulden J . Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. Am J Physiol 2003; 285: E449–E453.

    CAS  Google Scholar 

  16. Golden KL, Marsh JD, Jiang Y, Moulden J . Gonadectomy alters myosin heavy chain composition in isolated cardiac myocytes. Endocrine 2004; 24: 137–140.

    Article  CAS  Google Scholar 

  17. Malhotra A, Buttrick P, Sheuer J . Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 1990; 259: H866–H871.

    CAS  PubMed  Google Scholar 

  18. Rosenkratz-Weiss P, Tomek RJ, Mathew J, Eghbali M . Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol 1994; 26: 261–270.

    Article  Google Scholar 

  19. Herron T J, McDonald KS . Small amounts of α-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 2002; 90: 1150–1152.

    Article  Google Scholar 

  20. Herron TJ, Korte FS, McDonald KS . Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol 2001; 281: H1217–H1222.

    CAS  Google Scholar 

  21. Korte FS, Herron TJ, Rovetto MJ, McDonald KS . Power output is linearly related to myosin heavy chain content in rat skinned myocytes and isolated working hearts. Am J Physiol 2005; 289: H801–H812.

    CAS  Google Scholar 

  22. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, Leinwand LA . Expression of the β (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol 2000; 278: H412–H419.

    CAS  Google Scholar 

  23. Golden KL, Marsh JD, Jiang Y, Moulden J . Acute actions of testosterone on contractile function of isolated rat ventricular myocytes. Eur J Endocrinol 2005; 152: 479–483.

    Article  CAS  Google Scholar 

  24. Lin AL, Gonzalez R, Shain SA . Androgen directs apparent cytoplasmic and nuclear distribution of rat cardiovascular androgen receptors. Arteriosclerosis 1985; 5: 659–667.

    Article  CAS  Google Scholar 

  25. Haddad F, Masatsuga M, Bodell PW, Quin A, McCue A, Baldwin KM . Role of thyroid hormone and insulin in control of cardiac isomyosin expression. J Mol Cell Cardiol 1997; 29: 559–569.

    Article  CAS  Google Scholar 

  26. Christianson D, Roti E, Vagenakis AG, Braverman LE . The sex-related difference in serum thyrotropin concentration is androgen mediated. Endocrinology 1981; 108: 529–535.

    Article  CAS  Google Scholar 

  27. Katzeff HL, Bovbjerg D, Mark DA . Exercise regulation of triiodothyronine metabolism. Am J Physiol 1988; 255: E824–E828.

    CAS  PubMed  Google Scholar 

  28. Iemitsu M, Miyauchi T, Maeda S, Tanabe T, Takanashi M, Matsuda M et al. Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats. Am J Physiol 2004; 286: H1696–H1705.

    CAS  Google Scholar 

  29. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD et al. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 2001; 89: 591–598.

    Article  CAS  Google Scholar 

  30. Diffee GM, Seversen EA, Titus MM . Exercise training increases the Ca2+ sensitivity of tension in rat cardiac myocytes. J Appl Physiol 2001; 91: 309–315.

    Article  CAS  Google Scholar 

  31. Zabka AG, Mitchell GS, Behan M . Ageing and gonadectomy have similar effects on hypoglossal long-term facilitation in male Fischer rats. J Physiol 2005; 563: 557–568.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Support source: AstraZeneca (Macclesfield, Cheshire, UK) supplied the drug samples for this study.

Author information

Authors and Affiliations

  1. School of Sport and Exercise Science and the Rocky Mountain Cancer Rehabilitation Institute, University of Northern Colorado, Greeley, CO, USA

    D S Hydock, K Y Wonders, C M Schneider & R Hayward

Authors
  1. D S Hydock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Y Wonders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C M Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Hayward
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Hayward.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hydock, D., Wonders, K., Schneider, C. et al. Androgen deprivation therapy and cardiac function: effects of endurance training. Prostate Cancer Prostatic Dis 9, 392–398 (2006). https://doi.org/10.1038/sj.pcan.4500890

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500890

Keywords

This article is cited by

Search

Advanced search

Quick links